News
CYRX
17.41
+0.06%
0.01
Cryoport: Strong Pipeline Of Cell And Gene Therapy Approvals
Seeking Alpha · 2d ago
Weekly Report: what happened at CYRX last week (0914-0918)?
Weekly Report · 6d ago
BTIG Remains a Buy on CryoPort (CYRX)
TipRanks · 09/18 10:55
Cryoport Price Target Maintained With a $25.00/Share by BTIG
Dow Jones · 09/18 10:06
BTIG Reiterates Buy on CryoPort, Maintains $25 Price Target
Benzinga · 09/18 09:56
Weekly Report: what happened at CYRX last week (0907-0911)?
Weekly Report · 09/14 09:35
Weekly Report: what happened at CYRX last week (0831-0904)?
Weekly Report · 09/07 09:32
Weekly Report: what happened at CYRX last week (0824-0828)?
Weekly Report · 08/31 09:35
Weekly Report: what happened at CYRX last week (0817-0821)?
Weekly Report · 08/24 09:36
Cryoport Inc. Earnings Call Signals Cautious Upside
TipRanks · 08/18 00:29
Weekly Report: what happened at CYRX last week (0810-0814)?
Weekly Report · 08/17 09:36
CryoPort (CYRX) Upgraded to Buy: Here's Why
NASDAQ · 08/11 16:00
Weekly Report: what happened at CYRX last week (0803-0807)?
Weekly Report · 08/10 09:34
Cryoport Is Maintained at Buy by Guggenheim
Dow Jones · 08/07 17:03
Guggenheim Maintains Buy on CryoPort, Raises Price Target to $16
Benzinga · 08/07 16:53
Wall Street Analysts Are Bullish on Top Industrial Goods Picks
TipRanks · 08/07 14:10
Analysts Have Conflicting Sentiments on These Industrial Goods Companies: CryoPort (CYRX), Parker Hannifin (PH) and Icf International (ICFI)
TipRanks · 08/07 12:02
Cryoport price target raised to $16 from $12 at Guggenheim
TipRanks · 08/07 11:35
Cryoport price target raised to $21 from $15 at Roth Capital
TipRanks · 08/07 10:21
Cryoport Is Maintained at Buy by Needham
Dow Jones · 08/07 10:13
More
Webull provides a variety of real-time CYRX stock news. You can receive the latest news about Cryoport Inc through multiple platforms. This information may help you make smarter investment decisions.
About CYRX
Cryoport, Inc. is a provider of integrated, temperature-controlled supply chain solutions for the life sciences. The Company operates through two segments: segments: Life Sciences Services and Life Sciences Products. Its life sciences services include BioLogistics and BioStorage/BioServices, which provides temperature-controlled logistics, biostorage and bioservices within the life science industry through direct sales. Its life sciences products segment manufactures and sells cryogenic systems, such as freezers and cryogenic dewars and related ancillary accessories used in the storage and transport of life science commodities through direct sales or a distribution network. Its operating units include Cryoport Systems, CryoGene and MVE Biological Solutions (MVE). Cryoport Systems provides temperature-controlled BioLogistics, BioServices, and cryopreservation solutions, supporting clinical and commercial workflows through transport, kit production, labeling, packaging, and others.